PenCTU Trial Manager since January 2024, currently involved in the ERASE-LC, a feasibility study exploring anti-virals as a possible treatment for Long COVID, and BOOST, a randomised control trial investigating the effectiveness of HMB on improving physical function in liver cirrhosis.
I began my career in clinical research as a Research Administrator at the University of Liverpool, where I was involved in Pharmacology studies investigating Adverse Reactions. Following this, I took up post as a Junior Study Coordinator at Birmingham Children's Hospital CRF where I was the lead for the NIHR Rare-Diseases BioResource study. Between 2020-2023, I was the Trial Manager/Coordinator for a national, multi-site CTIMP study testing a new drug to improve recovery following haemorrhagic stroke (SCIL SAH) at Manchester CTU.
Qualifications
MSc (Hons) Cognitive Neuroscience, Aston University (2021)
BSc (Hons) Psychology, Lancaster University (2018)
Professional membership
UK Trial Manager's Network
Publications
Journals
Gaffney, C. J., Drinkwater, A., Joshi, S. D., O'Hanlon, B., Robinson, A., Sands, K. A., ... & Nuttall, H. E. (2021). Short-term immobilization promotes a rapid loss of motor evoked potentials and strength that is not rescued by rTMS treatment. Frontiers in human neuroscience, 15, 640642.